These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2857146)

  • 1. Disposition of disodium azodisalicylate in healthy subjects. A possible new drug for inflammatory bowel disease.
    van Hogezand RA; van Hees PA; Zwanenburg B; van Rossum JM; van Tongeren JH
    Gastroenterology; 1985 Mar; 88(3):717-22. PubMed ID: 2857146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.
    Willoughby CP; Aronson JK; Agback H; Bodin NO; Truelove SC
    Gut; 1982 Dec; 23(12):1081-7. PubMed ID: 7173720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis.
    Lauritsen K; Hansen J; Ryde M; Rask-Madsen J
    Gastroenterology; 1984 Jun; 86(6):1496-500. PubMed ID: 6143704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
    Lauritsen K; Hansen J; Bytzer P; Bukhave K; Rask-Madsen J
    Gut; 1984 Nov; 25(11):1271-8. PubMed ID: 6149981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U
    Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, metabolism, and excretion of salicylazosulfapyridine in man.
    Schröder H; Campbell DE
    Clin Pharmacol Ther; 1972; 13(4):539-51. PubMed ID: 4402886
    [No Abstract]   [Full Text] [Related]  

  • 7. Stability of disodium azodisalicylate (olsalazine) and metabolites in urine and faeces stored at different temperatures.
    van Hogezand RA; van Schaik A; van Hees PA; van Tongeren JH
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):261-5. PubMed ID: 3243321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatitis induced by disodium azodisalicylate.
    Poldermans D; van Blankenstein M
    Am J Gastroenterol; 1988 May; 83(5):578-80. PubMed ID: 2452567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis.
    Bondesen S; Nielsen OH; Schou JB; Jensen PH; Lassen LB; Binder V; Krasilnikoff PA; Danø P; Hansen SH; Rasmussen SN
    Scand J Gastroenterol; 1986 Aug; 21(6):693-700. PubMed ID: 2875518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestyramine-induced inhibition of salicylazosulfapyridine (sulfasalazine) metabolism by rat intestinal microflora.
    Pieniaszek HJ; Bates TR
    J Pharmacol Exp Ther; 1976 Jul; 198(1):240-5. PubMed ID: 6792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disodium azodisalicylate. American College of Gastroenterology Committee on FDA-Related Matters.
    Levinson RA
    Am J Gastroenterol; 1985 Mar; 80(3):203-5. PubMed ID: 2858154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and colon in vivo.
    Goerg KJ; Wanitschke R; Gabbert H; Breiling J; Franke M; Meyer zum Büschenfelde KH
    Digestion; 1987; 37(2):79-87. PubMed ID: 2887473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man.
    Fischer C; Maier K; Stumpf E; von Gaisberg U; Klotz U
    Eur J Clin Pharmacol; 1983; 25(4):511-5. PubMed ID: 6140167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of 5-aminosalicylic acid and its metabolite in human serum by front-face fluorometry: a simple and sensitive method.
    Hirsch RE; Lin MJ; Das KM
    J Lab Clin Med; 1990 Jul; 116(1):45-50. PubMed ID: 2376696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitro. Comparison with sulfasalazine and 5-aminosalicylic acid.
    Pamukcu R; Hanauer SB; Chang EB
    Gastroenterology; 1988 Oct; 95(4):975-81. PubMed ID: 2842215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine and 5-ASA compounds.
    Allgayer H
    Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sulfasalazine metabolites in rats following concomitant oral administration of riboflavin.
    Chungi VS; Dittert LW; Shargel L
    Pharm Res; 1989 Dec; 6(12):1067-72. PubMed ID: 2576130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olsalazine as an alternative therapy in a patient with sulfasalazine-induced eosinophilic pneumonia.
    Scherpenisse J; van der Valk PD; van den Bosch JM; van Hees PA; Nadorp JH
    J Clin Gastroenterol; 1988 Apr; 10(2):218-20. PubMed ID: 2901442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds.
    Rijk MC; van Schaik A; van Tongeren JH
    Scand J Gastroenterol; 1988 Jan; 23(1):107-12. PubMed ID: 2894070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans.
    Rasmussen SN; Bondesen S; Hvidberg EF; Hansen SH; Binder V; Halskov S; Flachs H
    Gastroenterology; 1982 Nov; 83(5):1062-70. PubMed ID: 7117789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.